gemcitabine has been researched along with monomethyl auristatin e in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerber, HP; Grewal, IS; Kissler, KM; Oflazoglu, E; Sievers, EL | 1 |
| Chen, LH; Feng, L; Hu, CY; Mostofa, AGM; Suthe, SR; Wang, MH; Wang, WL; Weng, TH; Wu, ZG; Yao, HP | 1 |
2 other study(ies) available for gemcitabine and monomethyl auristatin e
| Article | Year |
|---|---|
Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Deoxycytidine; Doxorubicin; Gemcitabine; Hodgkin Disease; Immunoconjugates; Ki-1 Antigen; Mice; Mice, SCID; Neoplasm Transplantation; Oligopeptides; Tubulin Modulators; Vinblastine | 2008 |
Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Carriers; Drug Synergism; Female; Fluorouracil; Gemcitabine; Humans; Immunoconjugates; Mice; Mice, Nude; Oligopeptides; Oxaliplatin; Pancreatic Neoplasms; Receptor Protein-Tyrosine Kinases; Xenograft Model Antitumor Assays | 2018 |